Simplex Trading’s Oncternal Therapeutics ONCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCT
Simplex Trading's ONCT Position: Q2 2023 in Review
Simplex Trading sold out of Oncternal Therapeutics (ONCT) in Q2 2023, closing a stake of 356 shares — an estimated $5K sold.
Simplex Trading first reported a position in ONCT in Q4 2014 and held it in 17 quarters. The position peaked at $319K in Q1 2021. 52 funds tracked by Wall St. Rank hold ONCT as of Q2 2023.
- Simplex Trading reported no remaining Oncternal Therapeutics position as of Q2 2023 after selling out during the quarter.
- Simplex Trading sold 356 Oncternal Therapeutics shares in Q2 2023, an estimated $5K.
- Simplex Trading first reported a position in Oncternal Therapeutics in Q4 2014 and held it in 17 quarters.
- Simplex Trading's Oncternal Therapeutics position peaked at $319K in Q1 2021.
- 52 funds tracked by Wall St. Rank held Oncternal Therapeutics as of Q2 2023.
Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.